Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|May 31, 2018
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experienceMohammed Salhab, Yazan Migdady, Melanie Donahue, et al.
Leukemia Research Reports|December 24, 2019
Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature reviewVladislav V Makarenko, Alec E Vaezi, Doreen B Brettler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 2019
Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 ExpressionBarry A Kriegsman, Pranitha Vangala, Benjamin J Chen, et al.
Leukemia Research Reports|June 24, 2014
Hemophagocytic lymphohistiocytosis secondary to T-cell/histiocyte-rich large B-cell lymphomaKatherine Devitt, Jan Cerny, Bradley Switzer, et al.
The American Journal of Surgical Pathology|April 8, 2014
MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS)Ruobing Xiao, Jan Cerny, Katherine Devitt, et al.
American Journal of Clinical Pathology|February 3, 2016
MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical PracticeMichael J Kluk, Caleb Ho, Hongbo Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignanciesBenjamin J Chen, Bjoern Chapuy, Jing Ouyang, et al.
Pageof 3